abstract |
The present invention relates to a compound of general formula (I) having dual pharmacological activity against sigma (σ) receptors and μ-opioid receptors, and more specifically, to a diazaspirodecyl compound having this pharmacological activity. Monoalkane compounds; processes for the preparation of such compounds; pharmaceutical compositions comprising them; and their use in therapy, in particular, in the treatment of pain. |